Accessibility Statement

Angiodroid S.p.A. is committed to ensuring that its digital presence is accessible and usable to the widest possible audience.

Scope of this website

Angiodroid.com is an institutional website intended exclusively for healthcare professionals, medical specialists, and business operators in the medical device sector. Access to the site is subject to a professional disclaimer presented upon entry.

Our commitment

We are actively working to improve the accessibility of this website in line with the Web Content Accessibility Guidelines (WCAG 2.1, Level AA) and the requirements of the European Accessibility Act (Directive (EU) 2019/882), as transposed into Italian law by Legislative Decree 82/2022.

We recognise that full conformance is an ongoing process. Our current efforts include:

  • Review and correction of image alternative text across all pages

  • Improvement of keyboard navigation and focus management

  • Enhancement of colour contrast ratios to meet WCAG 2.1 AA standards

  • Resolution of ARIA attribute issues within embedded third-party components

Known limitations

Some accessibility issues on this site originate from third-party embedded components (including form and navigation elements managed by our CMS platform). We are working with our technology providers to address these limitations.

Feedback and contact

If you experience any accessibility barrier on this website or require information in an alternative format, please contact us at:

Angiodroid S.p.A.
Via Speranza 35 — 40068 San Lazzaro di Savena (BO), Italy
info@angiodroid.com

We aim to respond to accessibility-related requests within 10 business days.

Last updated
June 2026